MedDataX Logo

Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32

NCT ID: NCT00047606

Last Updated: 2012-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-08-31

Study Completion Date

2003-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after six weeks of treatment in Caucasian and Japanese subjects.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98

NCT00047593

Open-Angle Glaucoma Ocular Hypertension
COMPLETED PHASE3

A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT04863365

Primary Open Angle Glaucoma Ocular Hypertension
UNKNOWN PHASE3

A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

NCT01628614

Glaucoma, Open-Angle Ocular Hypertension
COMPLETED

Effect of Lowering IOP in Glaucoma Suspects With HM

NCT04296916

Glaucoma, Suspect High Myopia
UNKNOWN NA

Survey of Patients Taking IOP-Lowering Eye Drops

NCT02384772

Glaucoma Ocular Hypertension
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Open-angle Glaucoma Ocular Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IOP Lowering Medications

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adults of Caucasian and Japanese Ethnicity
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C-02-32

Identifier Type: -

Identifier Source: secondary_id

C-02-32

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma
NCT01645319 COMPLETED
A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma
NCT04465630 TERMINATED NA
Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Primary Angle Closure Glaucoma
NCT02964676 UNKNOWN NA
A Multi-Dose Study With a Treatment for Open-Angle Glaucoma
NCT00705770 WITHDRAWN PHASE2/PHASE3
The Canadian Glaucoma Study
NCT00262626 TERMINATED NA
A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years
NCT01629407 COMPLETED
Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients
NCT02246777 COMPLETED NA
A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension
NCT01781962 TERMINATED
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
NCT01943721 COMPLETED PHASE1
Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma
NCT04619654 COMPLETED NA
IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy
NCT01766947 WITHDRAWN NA
Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)
NCT01540370 COMPLETED
IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy With Collagen Implant
NCT01561001 TERMINATED NA
Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)
NCT04658095 TERMINATED NA
Safety and Effectiveness of the Hydrus Microstent
NCT05198297 TERMINATED NA
Effectiveness of a Procedure for Previously Failed Glaucoma Surgery
NCT00347789 COMPLETED
Effect of IOP Lowering on Progressive HM
NCT05850936 RECRUITING NA
Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery
NCT01455467 COMPLETED NA
Correlation of Structure and Function in Glaucoma
NCT05954637 COMPLETED
One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
NCT01517477 COMPLETED NA
A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
NCT07216677 ACTIVE_NOT_RECRUITING
Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)
NCT00913029 COMPLETED PHASE4
High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP
NCT02312362 UNKNOWN NA
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
NCT04020705 COMPLETED NA
iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications
NCT03478293 TERMINATED NA